as of august 7, 2019, option care and bioscrip have merged to become one national team, solely dedicated to infusion care. option care health, inc. is the largest independent home and alternate site infusion services provider in the united states. with over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. through our clinical leadership, expertise and national scale, option care health is reimagining the infusion care experience for patients, customers and employees.
Company profile
Ticker
OPCH
Exchange
Website
CEO
John Rademacher
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Aveanna Healthcare • Enhabit • Signify Health • Chemed • Amedisys • Apria • LHC • Addus HomeCare • Natur International • AdaptHealth ...
Former names
BioScrip, Inc., MIM CORP
SEC CIK
Corporate docs
Subsidiaries
BioScrip Infusion Services, Inc. • BioScrip Infusion Services, LLC • BioScrip PBM Services, LLC • BioScrip Pharmacy Services, Inc. • CHI Holding Corporation • Chronimed, LLC • CHS Holdings, LLC • Clinical Holdings, Inc. • Clinical Specialties Network Services of Illinois, Inc. • Clinical Specialties, Inc. ...
IRS number
50489664
OPCH stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
23 Apr 24
8-K
Results of Operations and Financial Condition
23 Apr 24
ARS
2023 FY
Annual report to shareholders
3 Apr 24
DEFA14A
Additional proxy soliciting materials
3 Apr 24
DEF 14A
Definitive proxy
3 Apr 24
8-K
Regulation FD Disclosure
14 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
22 Feb 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Entry into a Material Definitive Agreement
11 Dec 23
Transcripts
OPCH
Earnings call transcript
2024 Q1
23 Apr 24
OPCH
Earnings call transcript
2023 Q4
22 Feb 24
OPCH
Earnings call transcript
2023 Q3
25 Oct 23
OPCH
Earnings call transcript
2023 Q2
27 Jul 23
OPCH
Earnings call transcript
2022 Q4
23 Feb 23
OPCH
Earnings call transcript
2022 Q3
27 Oct 22
OPCH
Earnings call transcript
2022 Q2
27 Jul 22
OPCH
Earnings call transcript
2022 Q1
28 Apr 22
OPCH
Earnings call transcript
2021 Q4
23 Feb 22
OPCH
Earnings call transcript
2022 Q4
23 Feb 22
Latest ownership filings
3
Femi Adewunmi
23 Apr 24
4
Barbara W. Bodem
3 Apr 24
4
Norman L. Wright
3 Apr 24
4
Luke Whitworth
12 Mar 24
4
Michael Bavaro
1 Mar 24
4
HARRY M JANSEN KRAEMER JR
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
4
Christopher L. Grashoff
27 Feb 24
4
MICHAEL H. SHAPIRO
27 Feb 24
4
JOHN CHARLES RADEMACHER
27 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 386.49 mm | 386.49 mm | 386.49 mm | 386.49 mm | 386.49 mm | 386.49 mm |
Cash burn (monthly) | 18.23 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 126.10 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 260.39 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 14.3 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
97.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 354 |
Opened positions | 72 |
Closed positions | 36 |
Increased positions | 150 |
Reduced positions | 87 |
13F shares | Current |
---|---|
Total value | 5.43 tn |
Total shares | 168.57 mm |
Total puts | 321.90 k |
Total calls | 3.41 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 20.82 mm | $673.55 bn |
Vanguard | 19.32 mm | $624.98 bn |
STT State Street | 5.73 mm | $185.29 bn |
Third Point | 5.45 mm | $176.33 bn |
Ubs Global Asset Management Americas | 4.94 mm | $159.72 bn |
Citadel Advisors | 4.75 mm | $153.53 bn |
Millennium Management | 4.25 mm | $137.57 bn |
Westfield Capital Management | 3.75 mm | $121.23 bn |
Geode Capital Management | 3.72 mm | $120.37 bn |
FMR | 3.72 mm | $120.25 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Norman L. Wright | Common Stock | Grant | Acquire A | No | No | 0 | 1,731 | 0.00 | 1,731 |
1 Apr 24 | Barbara W. Bodem | Common Stock | Grant | Acquire A | No | No | 0 | 1,731 | 0.00 | 1,731 |
9 Mar 24 | Luke Whitworth | Common Stock | Payment of exercise | Dispose F | No | No | 32.34 | 1,373 | 44.40 k | 117,880 |
28 Feb 24 | Michael Bavaro | Common Stock | Sell | Dispose S | No | No | 31.7259 | 1,984 | 62.94 k | 43,428 |
News
Option Care Health Q1 2024 GAAP EPS $0.26 Beats $0.23 Estimate, Sales $1.146B Beat $1.102B Estimate
23 Apr 24
Earnings Scheduled For April 23, 2024
23 Apr 24
Jefferies Maintains Buy on Option Care Health, Raises Price Target to $38
4 Mar 24
Barrington Research Maintains Outperform on Option Care Health, Raises Price Target to $38
23 Feb 24
Option Care Health Q4 EPS $0.32 Beats $0.29 Estimate, Sales $1.12B Beat $1.09B Estimate
22 Feb 24